Still a Place for Metoclopramide as a Prokinetic Drug in Critically Ill Patients?

Arthur R H van Zanten; Y Gert van der Meer; Willem A Venhuizen; Daren K Heyland

doi:10.1177/0148607114567711

Still a Place for Metoclopramide as a Prokinetic Drug in Critically Ill Patients?

JPEN J Parenter Enteral Nutr. 2015 Sep;39(7):763-6. doi: 10.1177/0148607114567711. Epub 2015 Jan 7.

Authors

Arthur R H van Zanten¹, Y Gert van der Meer², Willem A Venhuizen², Daren K Heyland³

Affiliations

¹ Department of Intensive Care, Gelderse Vallei Hospital, Ede, The Netherlands.
² Department of Hospital Pharmacy, Gelderse Vallei Hospital, Ede, The Netherlands.
³ Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada dkh2@queensu.ca.

PMID: 25567783
DOI: 10.1177/0148607114567711

No abstract available

Keywords: adverse reactions; cardiac side effects; early enteral nutrition; erythromycin; gastric emptying; gastric residual volume; metoclopramide; neurological side effects; off-label use; side effects.

MeSH terms

Critical Illness / therapy*
Dose-Response Relationship, Drug
Enteral Nutrition / methods
Humans
Intensive Care Units
Metoclopramide / pharmacology*

Substances

Metoclopramide